Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical trial NCT02949128 · COMPLETED
Trial details
- NCT number
- NCT02949128
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2023-01-24
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.